Since the observed difference in s.c. tumor growth results from loss of CD34 in non-hematopoietic cells and we have previously shown increased vascular leakage in an inflammatory model [11], we focused our studies on quantifying vascular integrity in tumors. The gene discussed is CD34; the disease is neoplasm.